Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2022-08-09 00:00:00 ET · period of report 2022-08-05 · accession 0000874015-22-000149 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-09 | 2022-08-05 | IONS | Swayze Eric | EVP Research | S - Sale | $45.20 | -1 | 20.4K | -0.0% | -$45.20 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-05 | S | D | 1 | $45.20 | 20,352 | D | — | — | (F1) Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 20, 2019. |